Atrium Biotechnologies développe et commercialise des ingrédients cosmétiques et nutritionnels innovateurs pour supporter les défenses ou les fonctions naturelles de l’organisme en utilisant des technologies de pointe.
« Notre position en tant qu’entreprise de recherche et de développement d’ingrédients actifs nous permet de nous classer parmi les leaders dans le domaine. »
Comme son nom le suggère, Atrium se veut le point de rencontre où clients et partenaires sont invités à exprimer leurs attentes pour que nous puissions y apporter des solutions durables et rentables. L’équipe d’Atrium, formée de scientifiques chevronnés et de spécialistes en commerce international, a le mandat d'analyser l'évolution des besoins de sa clientèle afin de mieux répondre aux exigences des marchés internationaux.
" Atrium Biotechnologies primarly develops and markets products worldwide to meet the needs of the most demanding health and personal care industry leaders."
As the name suggests, Atrium is a meeting place where customers and partners are invited to express their needs so that we can provide long-lasting, cost-effective solutions. The Atrium team consists of experienced scientists (chemists, pharmacists, engineers, logisticians) and international trade experts whose role is to monitor changing customer needs and acquire technologies allowing them to better meet the requirements of global markets.
Atrium’s Canadian team focuses on developing and marketing innovative cosmetic and nutritional ingredients that support the body’s natural defense systems and functions by using state-of-the-art technologies.
Through its European group of subsidiaries UNIPEX, CHIMIRAY and INTERCHEMICAL now representing a leader in its field, it provides importation and distribution services for specialty chemicals and active ingredients manufactured by a number of companies that were carefully selected for their innovative thinking and the impeccable quality of their products. In addition to supplying raw materials, these subsidiaries leverage the skills of their staff to support customers in the development of products incorporating its various partners’ innovations.
UNIPEX, CHIMIRAY and INTERCHEMICAL distribute raw materials and brand-name active ingredients to multinational firms in the cosmetic, industrial chemicals, fine chemicals, pharmaceutical and nutrition sectors.
Atrium Biotechnologies Inc. is a privately held subsidiary of Æterna Laboratories Inc. a Canadian biopharmaceutical company, dedicated to the development of new therapeutic approaches to cancer and other illnesses.
| | |
| Atrium Biotechnologies develops and manufactures innovative active ingredients for cosmetics. The quality of active ingredients, the expertise behind their research and development, and the pursuit of business opportunities with multinationals and the leaders in the cosmetics industry are all reasons why Atrium is becoming better and better known in the development of new cosmetics technologies. Some existing and future agreements with leading cosmetics firms involve the codevelopment of innovative ingredients with unique biological properties and superior safety profiles. In addition, a network of professional agents has enabled Atrium ingredients to obtain constant visibility and exposure throughout the cosmetic industry and will make it easier to introduce new active ingredients and technologies. In short, the effective, innovative ingredients developed and produced by Atrium Biotechnologies' Cosmetics Division address the special needs of the cosmetic industry. |
| The nutritional supplements and active ingredients developed and marketed around the globe, by Atrium Biotechnologies are the result of the most recent discoveries in biotechnology. We seek to offer innovative products that exceed the industry standards for quality and whose standardized components promote physiological equilibrium. Products commercialised by Atrium are now found in many countries of America, Europe and Asia. |